Randomized, double-blind, double-dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Efficacy and safety

被引：0

作者：

Olanow, C. W.

Antonini, A.

Kieburtz, K.

Fernandez, H. H.

Espay, A. J.

Standaert, D. G.

Vanagunas, A. D.

Widnell, K. L.

Freeman, S.

Robieson, W. Z.

Pritchett, Y.

Chatamra, K.

Benesh, J.

Lenz, R. A.

机构：

来源：

MOVEMENT DISORDERS | 2012年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

411

引用

页码：S131 / S132

页数：2

共 50 条

[11] Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease
Guthikonda, Lalitha N.
Lyons, Kelly E.
Pahwa, Rajesh
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2014, 3 (04) : 331 - 333
[12] Efficacy of levodopa-carbidopa intestinal GEL infusion on advanced Parkinson's disease patients at our hospital
Sakata, M.
Hiwatani, Y.
Matsumoto, T.
Minamino, M.
Hironishi, M.
Ito, H.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 728 - 728
[13] Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients
Slevin, John T.
Fernandez, Hubert H.
Zadikoff, Cindy
Hall, Coleen
Eaton, Susan
Dubow, Jordan
Chatamra, Krai
Benesh, Janet
JOURNAL OF PARKINSONS DISEASE, 2015, 5 (01) : 165 - 174
[14] Efficacy and safety of Levodopa-Carbidopa Intestinal Gel in the treatment of Parkinson's Disease
Londero, E.
dos Santos, A. P.
Braga, R.
de Barros, R.
dos Reis, L.
Freire, G.
MOVEMENT DISORDERS, 2021, 36 : S220 - S220
[15] BOUNDLESS: AN ACTIVE-CONTROLLED, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY TRIAL OF CONTINUOUS SUBCUTANEOUS INFUSION OF LEVODOPA/CARBIDOPA WITH ND0612 IN PATIENTS WITH PARKINSON'S DISEASE
Rascol, O.
Poewe, W.
Stocchi, F.
Yardeni, T.
Barak, S. Leibman
Adar, L.
Rosenfeld, O.
Olanow, C. W.
PARKINSONISM & RELATED DISORDERS, 2020, 79 : E53 - E53
[16] Levodopa-carbidopa intestinal gel for advanced Parkinson's disease
Bohlega S
Abou Al-Shaar H
Alkhairallah T
中华物理医学与康复杂志, 2016, (03) : 179 - 179
[17] Efficacy of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Subgroup analyses
Standaert, D. G.
Slevin, J. T.
Espay, A. J.
Boyd, J. T.
Fernandez, H. H.
Pritchett, Y.
Zhang, W.
Chatamra, K.
Widnell, K. L.
Benesh, J.
MOVEMENT DISORDERS, 2013, 28 : S143 - S144
[18] Effect of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
Takei, T.
Uozumi, T.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 742 - 742
[19] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial (vol 43, pg 465, 2024)
Espay, A. J.
Stocchi, F.
Pahwa, R.
LANCET NEUROLOGY, 2024, 23 (06): : E10 - E10
[20] Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients: Design of a Phase 3, Randomized, Double-Blind, Double-Dummy, Active Controlled 12-Week Trial
Facheris, Maurizio
Robieson, Weining
Fisseha, Nahome
Standaert, David
NEUROLOGY, 2021, 96 (15)

← 1 2 3 4 5 →